Market Place
Sourcing Support
Alkem Labs Q2FY25 Profit Rises 11%, Revenue Falls Marginally
13 Nov 2024 //
FINANCIALXPRESS
CDSCO flags 49 medicine for failing quality; 4 declare as spurious
26 Oct 2024 //
ECONOMICTIMES
Cipla, Alkem Laboratories in final lap to buy SMT
16 Oct 2024 //
ECONOMICTIMES
PE firms queue up for Novartis` Indian arm
12 Oct 2024 //
ECONOMICTIMES
Sonnet Bio Enters into Licensing Agreement with Alkem Laboratories
09 Oct 2024 //
GLOBENEWSWIRE
Alkem Labs denies claims of Pan-D, Clavam 625 batches
27 Sep 2024 //
ECONOMICTIMES
Alkem Lab`s Generics Ticagrelor Receives Tentative Approval in US
12 Sep 2024 //
FDA
Alkem joins $3 bn race for JB Chem as Torrent pauses talks
12 Sep 2024 //
ECONOMICTIMES
Alkem inks licensing pact with Takeda to introduce Vonoprazan in India
03 Sep 2024 //
ECONOMICTIMES
Alkem`s Generics Riluzole Receives Approval in US
22 Aug 2024 //
FDA
Alkem arm ties up with Exactech for knee, hip replacement implants
22 Aug 2024 //
ECONOMICTIMES
Alkem Labs Generic Topiramate Receives Approval in US
13 Jun 2024 //
FDA
Alkem Labs Generic Elagolix Receives Tentative Approval in US
12 Jun 2024 //
FDA
Alkem Labs collaborates with 100 hospitals in tier-1 & tier-2 cities
06 May 2024 //
PHARMABIZ
US FDA releases details of observations on Alkem`s Baddi Plant
10 Apr 2024 //
MONEYCONTROL
FDA Issues form 483 to Alkem Laboratories Limited
10 Apr 2024 //
FDA
Alkem Lab`s Generic Cefprozil Receives Approval in the U.S.
09 Apr 2024 //
FDA
Alkem Laboratories sinks 3 percent on US FDA`s 10 observations for Himachal unit
28 Mar 2024 //
MONEY CONTROL
SKCDA asks Alkem to recall anti-reflux drug PAN-D which are fake batch
22 Mar 2024 //
PHARMABIZ
Alkem Lab`s Generic Mirabegro Receives Approval in the U.S.
12 Feb 2024 //
FDA
Alkem completes sale of St. Louis manufacturing facility for US$ 7.96 million
31 Dec 2023 //
INDIAN PHARMA POST
USFDA inspection at Alkem Lab API manufacturing facility located at Mandva
02 Dec 2023 //
INDIAN PHARMA POST
Alkem Laboratories` Generic Brexpiprazole Receives Approval in the U.S.
28 Nov 2023 //
FDA
Alkem ‘Healthy Lungs` initiative aims to clear the air
31 Oct 2023 //
INDIAN PHARMA POST
Alkem rolls out patient awareness drive under its breathe initiative
28 Sep 2023 //
INDIAN PHARMA POST
Enforcement Report - Week of July 26, 2023
26 Jul 2023 //
FDA
Alkem`s Generic Tapentadol Receives Approval in the U.S.
07 Jul 2023 //
FDA
Alkem`s Generic (Topiramate) Receives Approval in the U.S.
20 Jun 2023 //
FDA
Alkem Labs to grow chronic therapies, biosimilars to drive future growth: MD
06 Jun 2023 //
ECONOMIC TIMES
Alkem`s Generic Dapagliflozin, Metformin HCL Receives Approval in the U.S.
04 May 2023 //
FDA
ALKEM launches asthma awareness campaign #RelieverFreeIndia
02 May 2023 //
EXPRESS PHARMA
Enforcement Report - Week of April 26, 2023
26 Apr 2023 //
FDA
Enforcement Report - Week of April 5, 2023
05 Apr 2023 //
FDA
Ascend Labs recalls anticoagulant pills on carcinogen concerns
23 Mar 2023 //
FIERCE PHARMA
Alkem subsidiary Enzene launches adalimumab biosimilar in India
23 Feb 2023 //
ECONOMIC TIMES
Enforcement Report - Week of February 22, 2023
22 Feb 2023 //
FDA
Enforcement Report - Week of February 1, 2023
01 Feb 2023 //
FDA
Alkem to launch novel antibiotic for MDR infections
31 Jan 2023 //
INDIAN PHARMA POST
Alkem`s Generic Mirabegron Receives Approval in the U.S.
09 Jan 2023 //
FDA
Jazz sues generics for infringement on cannabis-derived drug
06 Jan 2023 //
FIERCE PHARMA
Alkem`s Generic Lurasidone Hydrochloride Receives Approval in the U.S.
13 Dec 2022 //
FDA
Alkem`s Generic Eslicarbazepine Acetate Receives Approval in the U.S.
07 Dec 2022 //
FDA
Alkem launches healthy lungs portal to spread awareness about paediatric asthma
15 Nov 2022 //
PHARMABIZ
Alkem`s Generic Vancomycin Hydrochloride Receives Approval in the U.S.
14 Nov 2022 //
FDA
USFDA issues Form-483 with 3 observations to Alkem Lab`s St Louis plant
10 Nov 2022 //
ECONOMIC TIMES
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
31 Oct 2022 //
ENDPTS
Alkem’s Fenton, Mo., Plant Slapped with 483 for Equipment, Process Control Issues
11 Oct 2022 //
FDA NEWS
Alkem`s Generic Empagliflozin Receives Approval in the U.S.
28 Sep 2022 //
FDA
Alkem and Stempeutics launch StemOne for treatment of knee osteoarthritis
19 Sep 2022 //
ECONOMIC TIMES
Alkem`s Generic Tolvaptan Receives Approval in the U.S.
06 Sep 2022 //
FDA
Alkem Laboratories’ net profit declined by 72.7% in Q1
11 Aug 2022 //
PHARMABIZ
Alkem`s Generic Empagliflozin, Linagliptin Receives Approval in the U.S.
09 Aug 2022 //
FDA
Alkem Lab Generic Diclofenac Potassium Receives Approval in the U.S.
20 Jul 2022 //
FDA
Alkem Lab facility gets Form 483 with 3 observations from USFDA
20 Jun 2022 //
BUSINESS STANDARD
Alkem Laboratories`s Generic Enalapril Maleate Receives Approval in the U.S.
30 Mar 2022 //
FDA
Alkem Laboratories`s Generic Nifedipine Receives Approval in the U.S.
29 Mar 2022 //
FDA
